Luminex Corp.

Luminex Corp.

Luminex Corp.

Overview
Date Founded

1998

Headquarters

12212 Technology Boulevard,Suite 130,Austin, TX 78727

Type of Company

Public

Employees (Worldwide)

1,325

Industries

Medical Products & Equipment
Industrial Machinery & Manufacturing
IT Consulting & Services
Medical Support Services
Biotechnology

Company Description

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Contact Data
Trying to get in touch with decision makers at Luminex Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Senior Director, Investor Relations

Chief Financial Officer, Senior Vice President, Finance & Treasurer

Senior Vice President-Human Resources

Senior Vice President, Research & Development

Senior Vice President, Global Manufacturing & Quality

Senior Vice President, Global Sales & Customer Operations

Senior Vice President, Global Marketing

Vice President, Accounting

Board of Directors

Chairman, President & Chief Executive Officer at Luminex Corp.

President & Chief Executive Officer at Medstar Health, Inc.

Vice Chairman at Tyson Foods, Inc.

General Partner at Relevance Ventures

Former Chief Executive Officer at Western Dental Services, Inc.

Chairman at Amnis Corp.

Senior Vice President, Clinical Development & Chief Medical Officer at MacroGenics, Inc.

Executive Vice President, Consumer Products & Enterprise Marketing at Healthagen LLC

Paths to Luminex Corp.
Potential Connections via
Relationship Science
You
Luminex Corp.
Owners & Shareholders
Details Hidden

RGM Capital is a value-oriented investor with an emphasis on small-cap equities. The firm invests for the long-term with the expectation of significant stock price appreciation through various catalysts including improved operating performance, asset disposals, changes in their capital structure, or a higher profile with the broader investment community. They seek businesses that possess favorable financial and operating characteristics including significant cash flow generation, cash-rich balance sheets, dominant market shares, pricing power, and recurring revenue streams.

Details Hidden

CCM offers investment strategies that employ fundamental, quantitative, macro-economic and technical analysis. They use the following sources of information for its analysis: financial newspapers and magazines; inspections of corporate activities; research materials prepared by others; corporate rating services; timing services; annual reports; filings with the SEC; and company press releases. Their investment strategies emphasize securities purchases held for the long term (more than 12 months), however, from time to time, due to rapid changes in either the market or a given security’s fundamentals, it is possible that we may execute a short term (sold within one year) or trading (selling securities within 30 days) strategy.

Details Hidden

Investment Management of Virginia (IMVA) offers the following portfolios to their clients: Large Cap Core Equity, Large Cap Balanced, Small Cap, Energy, Select Equity Income, Opportunity, Special and International.

Recent Transactions
Details Hidden

DiaSorin SpA purchases Luminex Corp.

Details Hidden

Luminex Corp. purchases EMD Millipore Corp. /Flow Cytometry Assets from Merck KGaA

Details Hidden

Luminex Corp. purchases Amnis Corp. from Merck KGaA

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Investment Advisor

Advised onLuminex Corp. purchases Nanosphere, Inc.

Legal Advisor

Advised onLuminex Corp. purchases Nanosphere, Inc.

Legal Advisor

Advised onLuminex Corp. purchases EraGen Biosciences, Inc.

Chair, Corporate Practice Department

Advised onLuminex Corp. purchases Nanosphere, Inc.

Professional

Advised onLuminex Corp. purchases EraGen Biosciences, Inc.

Managing Director

Advised onLuminex Corp. purchases GENTURAdx USA, Inc.

Advisors & Consultants
Advisor

Executive Advisor at Water Street Healthcare Partners LLC

Advisor

Former Corporate Secretary, Senior Vice President & General Counsel at Luminex Corp.

Legal Advisor

Former Partner at DLA Piper

Clients

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines, as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Our goal, at Myriad, is to make a difference in patient’s lives and for the past twenty years, the Company’s strategy has been guided by this mission. To accomplish this, we are focused on revolutionizing patient care through the development and marketing of transformative tests which address pressing clinical needs across multiple medical specialties. Over the last twenty years, Myriad has invested heavily in the education of patients and health care providers on the role genes and their related proteins play in disease. Almost one million patients have already benefited from Myriad’s informative testing, which helps physicians better manage their health care. Today, Myriad continues to build on this strong tradition. We are working to expand our reach by introducing new genetic tests and molecular diagnostic tests for a number of diseases. We also are focused on extending our mission internationally, in an effort to broaden our geographic footprint and provide critical information to more patients and healthcare providers

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Key Stats and Financials As of 2020
Market Capitalization
$1.74B
Total Enterprise Value
$972M
Earnings Per Share
$0.32
Revenue
$417M
EBITDAMargin
17.47%
Net Profit
$14.9M
Total Equity
$518M
EBITDA
$72.9M
Total Debt
$222M
Enterprise Value EBITDAOperating
13.07x
Debt TEV
0.23x
TEVNet Income
65.38x
Enterprise Value / Sales
2.33x
Suppliers
PS Business Parks, Inc. Real Estate | Glendale, CA

PS Business Parks, Inc. (NYSE: PSB) is a publicly traded full service real estate company with expertise in leasing, property management, acquisition and development. As of October 2012 the Company owned and operated approximately 28.3 million rentable square feet of commercial space located in eight states: Arizona, California, Florida, Maryland, Oregon, Texas, Virginia, and Washington. The Company also manages approximately 1.2 million rentable square feet on behalf of Public Storage, Inc. and its affiliated entities. PS Business Parks was organized in 1986 as a division of a predecessor of Public Storage. Since becoming public in 1998, PS Business Parks’ portfolio has grown from 5 million square feet by applying a disciplined investment approach. We have focused on “flex” properties that can be easily configured to suit a variety of uses and are located in high population growth markets near decision maker housing. This property type supports a wide variety of uses and customers. In each of the markets where we own properties we hire a professional team of skilled local real estate experts who are empowered to make ownership decisions and motivated to provide a high level of service to our customers. The Company’s investment objective is to maximize shareholder value by achieving long-term growth in net asset value per share. Key elements of PS Business Parks’ growth strategy include: maximizing portfolio cash flow, maintaining focus on core markets, acquiring and developing well positioned quality properties where valuations are justified, continuing to attract a diversified tenant base, developing new tenant services and providing superior tenant service.

AnteoTech Ltd. Biotechnology | Eight Mile Plains, Australia

AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. Its products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The company was founded in 1999 and is headquartered in Eight Mile Plains, Australia.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

General Electric Company Power & Utilities - Boston, MA

General Electric Co. engages in the provision of technology and financial services. It operates through the following segments: Power, Renewable Energy, Aviation, Healthcare, and Capital. The Power segment offers technologies, solutions, and services related to energy production, which includes gas and steam turbines, generators, and power generation services. The Renewable Energy segment provides wind turbine platforms, hardware and software, offshore wind turbines, solutions, products and services to hydropower industry, blades for onshore and offshore wind turbines, and high voltage equipment. The Aviation segment provides jet engines and turboprops for commercial airframes, maintenance, component repair, and overhaul services, as well as replacement parts, additive machines and materials, and engineering services. The Healthcare segment provides healthcare technologies in medical imaging, digital solutions, patient monitoring, and diagnostics, drug discovery, biopharmaceutical manufacturing technologies and performance enhancement solutions. The Capital segment leases and finances aircraft, aircraft engines and helicopters, and also provides financial and underwriting solutions. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Boston, MA.

Agilent Technologies, Inc. Industrial Machinery & Manufacturing - Santa Clara, CA

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Luminex Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Luminex Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Luminex Corp..